Fig. 4From: The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysisThe global prevalence of a) Daptomycin and b) linezolid-resistant S. aureus, MRSA and CoNSBack to article page